Sio Capital Management, LLC Cellectar Biosciences, Inc. Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$11.8 - $18.2 $25.8 Million - $39.8 Million	-2,188,058 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$15.2 - $25.0 $2.17 Million - $3.58 Million	-143,065 Reduced 6.14%	2,188,058 $3.52 Million
Q4 2020 Feb 16, 2021	BUY	$11.2 - $27.7 $10.8 Million - $26.8 Million	966,666 Added 70.85%	2,331,123 $4.85 Million
Q3 2020 Nov 16, 2020	BUY	$10.6 - $16.6 $12.5 Million - $19.5 Million	1,175,000 Added 620.19%	1,364,457 $1.69 Million
Q2 2020 Aug 14, 2020	BUY	$10.3 - $17.3 $1.95 Million - $3.28 Million	189,457 New	189,457 $243,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $1.47M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.